6-K ·Filed Apr 23, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor for any updates or commentary from management during the conference, but expect minimal immediate market impact. The event may provide insight into the company's strategy amid its ongoing funding concerns highlighted in the prior 20-F filing.
Final — all horizons settled through T+60d
IPHYF ▲ +10.00% at T+60d
NEUTRAL call +10.00% · α vs SPY +4.98% · entry $1.50 → $1.65
T+1d
0.00%
call 0.00% · α -0.78%
$1.50
settled 6mo ago
T+5d
0.00%
call 0.00% · α -1.48%
$1.50
settled 6mo ago
T+20d
+50.00%
call +50.00% · α +45.37%
$2.25
settled 5mo ago
T+60d
+10.00%
call +10.00% · α +4.98%
$1.65
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Innate Pharma announced executive participation in the D. Boral Capital Global Conference on May 7, 2026, for investor meetings. This is a routine investor relations update with no new financial or clinical data disclosed.
Key Facts
- Company to participate in D. Boral Capital Global Conference on May 7, 2026, in New York
- No new clinical, financial, or operational updates provided
- Event involves one-on-one investor meetings, not a public presentation
Financial Impact
No immediate financial impact
Risk Factors
- Continued uncertainty around financing needs for lacutamab development
- No substantive update provided; reliance on future disclosures for material information
Market Snapshot
Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-026676 |
| Document: a6k-iphx260423.htm | 0001628280-26-026676 |
| Document: 0001628280-26-026676-index-headers.html | 0001628280-26-026676 |
| Document: 0001628280-26-026676-index.html | 0001628280-26-026676 |
| Document: 0001628280-26-026676.txt | 0001628280-26-026676 |
10 reports for IPHYF
33% Hit rate @ T+60 Went positive at some point 1 of 3 best @ T+20▲ +50.00%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
May 19, 2026 22w ago | 6-K | $2.25 $1.65 | ▼ −26.67% | ▼ −32.96% | $1.51 (−32.93%) |
May 13, 2026 23w ago | 6-K | $1.50 $1.65 | ▼ −10.00% | ▼ −5.56% | $1.51 (−0.60%) |
May 6, 2026 24w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +7.94% | $1.51 (+0.60%) |
Apr 23, 2026 26w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +4.98% | $1.51 (+0.60%) |
Apr 17, 2026 27w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +3.86% | $1.51 (+0.60%) |
Apr 13, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +11.25% | $1.51 (+9.91%) |
Apr 13, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +11.25% | $1.51 (+9.91%) |
Apr 8, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +9.72% | $1.51 (+9.91%) |
Apr 3, 2026 29w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +6.71% | $1.51 (+9.91%) |
Apr 1, 2026 29w ago | 20-F | $1.37 $1.65 | ▼ −20.17% | ▼ −6.80% | $1.51 (−9.91%) |
Showing 10 of 10
US Market Status
Market Closed — Opens in 6h 17m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers